Botanix Pharmaceuticals Ltd

BOT

Company Profile

  • Business description

    Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.

  • Contact

    41 - 47 Colin Street
    Suite 3
    West PerthWA6005
    AUS

    T: +61 865552945

    https://www.botanixpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    1

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,757.9013.20-0.15%
CAC 407,656.1227.61-0.36%
DAX 4023,317.81116.84-0.50%
Dow JONES (US)42,171.6644.14-0.10%
FTSE 1008,843.479.440.11%
HKSE23,710.69269.61-1.12%
NASDAQ19,546.2725.180.13%
Nikkei 22538,885.15348.410.90%
NZX 50 Index12,611.9915.33-0.12%
S&P 5005,980.871.85-0.03%
S&P/ASX 2008,531.2010.10-0.12%
SSE Composite Index3,388.811.400.04%

Market Movers